Heidi Health has launched Heidi II, adding AI agents that handle administrative tasks around patient visits while the company insists clinicians retain final approval over decisions.
Healthleap raised $38 million to expand its AI-driven patient screening platform to identify additional medical conditions, part of a broader wave of funding for AI tools aimed at catching diagnoses earlier.
Healthleap raised $38 million after growing from three to more than 50 hospital customers in a year, betting that an AI tool which mines clinical notes for missed diagnoses can prove hard financial ROI, not just clinical promise.
A Blue Cross Blue Shield Association analysis estimates AI-assisted medical coding tools added roughly $942 million in questionable hospital charges between 2023 and 2025, a claim the American Hospital Association disputes.
Suki's $90 million raise for AI agents that handle health system administrative work reflects sustained investor confidence in tools aimed at reducing physician documentation burden.
SimBioSys's newly FDA-cleared TumorSight Risk tool combines imaging, pathology and clinical data to score breast cancer recurrence risk, part of a wave of AI oncology clearances this year.
Utah's new verification system for its healthcare AI sandbox reflects a distinct state-level regulatory approach, part of an increasingly fragmented patchwork of state and federal health AI oversight.
PhilHealth is weighing an AI system to catch mismatched lab tests and diagnoses before paying claims, part of a global shift toward pre-payment fraud detection in health insurance.
The Africa Health-Tech Accelerator's 2026 cohort targets AI diagnostics and supply chains alike, reflecting growing but still modest investment in African health tech relative to funding rounds elsewhere.
A new analysis finds most health plans now use AI for prior authorization approvals, but a meaningful share also use it for denials — a distinction advocates say current federal AI policy dangerously fails to make.